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Abstract: The adaptation and progress of 3D printing technology toward 3D bioprinting (specifically
adapted to biomedical purposes) has opened the door to a world of new opportunities and possibili-
ties in tissue engineering and regenerative medicine. In this regard, 3D bioprinting allows for the
production of tailor-made constructs and organs as well as the production of custom implants and
medical devices. As it is a growing field of study, currently, the attention is heeded on the optimization
and improvement of the mechanical and biological properties of the so-called bioinks/biomaterial
inks. One of the strategies proposed is the use of inorganic ingredients (clays, hydroxyapatite,
graphene, carbon nanotubes and other silicate nanoparticles). Clays have proven to be useful as
rheological and mechanical reinforcement in a wide range of fields, from the building industry to
pharmacy. Moreover, they are naturally occurring materials with recognized biocompatibility and
bioactivity, revealing them as optimal candidates for this cutting-edge technology. This review deals
with the use of clays (both natural and synthetic) for tissue engineering and regenerative medicine
through 3D printing and bioprinting. Despite the limited number of studies, it is possible to conclude
that clays play a fundamental role in the formulation and optimization of bioinks and biomaterial
inks since they are able to improve their rheology and mechanical properties, thus improving print-
ability and construct resistance. Additionally, they have also proven to be exceptionally functional
ingredients (enhancing cellular proliferation, adhesion, differentiation and alignment), controlling
biodegradation and carrying/releasing actives with tissue regeneration therapeutic activities.
Keywords: clay; nanosilicate; phyllosilicate; tissue engineering; regenerative medicine; 3D printing;
3D bioprinting; bioink
1. Introduction
Three-dimensional printing (3D printing) is a relatively recent technique used to
model and fabricate three-dimensional constructs with a layer-by-layer procedure. In this
technique, computer or software-aided design (CAD) is used to create and generate a
g-code that will be read by the 3D printer to fabricate the desired item. Currently, there
are several 3D printing technologies available, depending on the nature of the materials
used for the printing process and the final scope of the printed construct itself. Since its
appearance, 3D printing has influenced a significant number of areas, from construction,
mechanics, industry or art to medicine and healthcare. Its versatility and potential are
especially highlighted when it comes to the biomedical field, area in which it acquires the
Pharmaceutics 2021, 13, 1806. https://doi.org/10.3390/pharmaceutics13111806 https://www.mdpi.com/journal/pharmaceutics
Pharmaceutics 2021, 13, 1806 2 of 46
denomination “3D bioprinting” (3DBP) or “bioprinting” to clearly differentiate it from the
rest of the 3D printing applications (Table 1).
Table 1. Main differences between 3D bioprinting (3DBP) and 3D printing (3DP).
Properties 3DBP 3DP
Nature, type and
characteristics of the ink
ingredients
Biological and biocompatible materials (BMI),
sometimes laden with human or mammalian
cells (BI).
Liquid or semisolid, gel-like materials
(aqueous-rich).
Usually, post-processing steps are needed to
improve the resistance and manageability of the
construct (chemical or physical crosslinking
methods such as light-based crosslinking, among
many others).
Molten plastics, synthetic polymers, metal
alloys, ceramics, concrete, etc.





The “bioprinters” require less robustness: they
usually work at low temperatures, pressures,
speeds, etc.
These mild working conditions guarantee
cellular viability.
High precision is mandatory to reproduce native
tissue structures.
Robust equipment, able to work in extreme
conditions (high temperatures and/or
pressures). No need to ensure cellular
viability.
Precision depends on the item and its final
scope (i.e., less precision for building




Extrusion-based bioprinting, droplet (or inkjet)
bioprinting and laser-based bioprinting.
Fused-deposition modelling, selective laser
sintering, stereolithography, multi-jet fusion.
Bioprinting is a growing and promising technology that allows for the fabrication
of new dosage forms, tailor-made devices and implants, tailor-made scaffolds for tissue
engineering (TE), and many other individualized therapy options [1]. Until the appearance
of 3DBP, the major part of the TE approaches was based and limited to two-dimensional
cell sheets. Currently, 3DBP is able to provide cell-laden three-dimensional structures with
extracellular matrix (ECM) ingredients possessing the right shape and size to be directly
implanted in a certain patient. Moreover, 3DBP offers the possibility to reproduce complex
tissue-engineered constructs.
“Bioink” (BI) is the term used to refer to a cell-laden, biocompatible material intended
to be three-dimensionally bioprinted [2]. The concept of BI is, in fact, what defines the
boundary between 3DBP and conventional 3DP (Table 1) [1,3]. Most of the time, the BI
formulations are hydrogel-based since they are formed by water-rich materials that more
closely reproduce the extracellular matrix (ECM) environment. On the contrary, if cells are
not present in the material to be printed, it can be defined as a “biomaterial ink” (BMI) [2,4].
Even if the BMI is printed and cells are subsequently seeded over the printed construct, this
formulation does not qualify as BI, as suitable pointed out by Groll and co-workers [2]. The
use of biocompatible and biodegradable ingredients, together with the inclusion of cells
within the so-called BI, make it possible to print customized structures and/or tissues with
minimal healing time as well as minimal chances of implant rejection and other immune
responses. At present, 3DBP has enabled the in vitro production of complex tissues such
as skin, cartilage, bone, lung or heart. 3DBP can be defined as a “super multi-discipline
technology involving tissue biology, cell biology, computer technology, materials science
and medical sciences” [5].
Biocompatible polymers (both natural and synthetic) are the main ingredient of BIs
and BMIs. Among today’s most used natural BI ingredients, alginate, gelatin, collagen
(type I), chitosan, silk fibroin, albumin, agarose, thrombin, fibrinogen, hyaluronic acid,
chitosan, chitin and cellulose [1,6] can be highlighted. These ingredients are able to form
hydrogels (by different mechanisms), thus retaining high amounts of water and offering
remarkable porosity. These aqueous and porous networks enable the permeability and
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diffusion of nutrients and gasses, thus emulating a favorable micro-environment for cell
growth. Nonetheless, the major part of the aforementioned natural ingredients possesses
poor mechanical properties, shape and time-stability, which are crucial features for bioprint-
ing. For these reasons, synthetic, biocompatible ingredients such as gelatin methacryloyl,
pluronic, polyethylene glycol, polyglycolic acid, poly(lactic acid), polycaprolactone or
polylactic-co-glycolic are used and often combined with natural ingredients in order to
reach a correct balance between biocompatibility, biodegradability, functionality and proper
mechanical properties of the BI or BMI [1]. Regarding the improvement of BI mechanical
properties, some inorganic ingredients, particularly those with well-known biocompat-
ibility such as hydroxyapatite, graphene, carbon nanotubes, clay minerals, zeolites and
other silicate nanoparticles, are currently in the spotlight [1,3,7–10]. The present review
specifically focuses on the current uses of clay minerals for 3DBP, aiming to provide a com-
prehensive overview of the potential of these minerals as ingredients of BIs and BMIs. The
following section will be specifically dedicated to describing these inorganic ingredients,
including an overview of their most characteristic physicochemical properties.
1.1. Clay Minerals
The term “clay mineral” refers to a group of minerals (natural or synthetic) grouped
as “phyllosilicates”. Chemically speaking, phyllosilicates are hydrated aluminosilicate
minerals composed of aluminum and silicon oxides that also contain a high amount of
cations such as Mg, K, Ca, Na and Fe. Structurally speaking, phyllosilicates are formed
by continuous, stacked, tetrahedral and octahedral sheets. Each tetrahedron consists of
Si4+ cations coordinated to four oxygen atoms orientated in an infinite two-dimensional
hexagonal mesh pattern (Figure 1A). The octahedral stratum is formed by the coordination
of metal cations (mainly Mg, Al, Fe, Li, etc.) with oxygen atoms, OH− or F− of the
tetrahedral sheet. Each octahedron share edges with one another to form a continuous
sheet with hexagonal or pseudo-hexagonal symmetry (Figure 1B). The tetrahedral and
octahedral sheets are associated with the apical oxygen atom of the tetrahedral sheet.
Depending on the type of association, phyllosilicates can be classified as 1:1 (also known as
T:O) or 2:1 (or T:O:T) (Figure 1C).
Figure 1. Schematic representation of (A) basic phyllosilicate tetrahedron and spatial disposition of
tetrahedral sheets and (B) octahedron and spatial disposition of octahedral sheets. (C) Phyllosilicates
layer structures 2:1 (T:O:T) and 1:1 (T:O).
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Although the most accepted classification of clay minerals usually depends on their
structure and chemical composition (mineralogical classification) [11], in this manuscript,
we mainly differentiate clay minerals by their crystal habits or macroscopic aspect (Figure 2).
Therefore, we can differentiate between:
• Layered clay minerals such as montmorillonite (MMT), hectorite (HT), or laponite
(LAP);
• Tubular clay minerals, where halloysite nanotubes (HNTs) are included;
• Fibrous clay minerals or “non-planar phyllosilicates”, a group formed by sepiolite
(SEP) and palygorskite (PAL, also known as attapulgite).
Figure 2. Structure and microphotographs of (A) layered clay minerals, (B) tubular clay minerals
and (C) fibrous clay minerals. The SEM microphotograph of halloysite nanotubes (B) was adapted
with permission from [12], Elsevier, 2021.
In the particular case of layered clay minerals (Figure 2A), it is possible to find an
“interlayer space” between each T:O or T:O:T stack. This interlayer space is of great im-
portance since it provides clay minerals with useful properties. For instance, due to the
interlayer space, they are able to “swell” in an aqueous environment, thus behaving as
hydrogels at the proper concentration. This swelling behavior consists of the adsorption of
water, leading to increased interlayer space and improvement in the volume occupied by
the clay–water suspension. In fact, under optimum conditions, the layers can completely
dissociate, leading to clay mineral delamination or exfoliation [13]. Inside this, we can
find a quite famous synthetic clay called Laponite®. LAP is a synthetic clay mineral with a
hectorite-like chemical composition whose name was introduced by Laporte Industries in
the 1960s (currently named BYK Additives Ltd.) [14]. The use of LAP has historically fo-
cused on the chemical and construction industry mainly as a rheological additive for paints,
household cleaning products, adhesives, automotive and wood coatings, ceramic glaze,
etc. Nonetheless, its useful properties and its synthetic origin (which implies the absence
of other mineral impurities typically accompanying natural clay minerals) have allowed
its use to be extended to a wide variety of areas, including medicine or pharmacy [15].
Therefore, in comparison with its natural counterpart HT, LAP possesses a superior purity
and very small particle size (20–50 nm diameter and 1–2 nm thickness), which allow it to
Pharmaceutics 2021, 13, 1806 5 of 46
produce transparent colloidal and gel-like suspensions maintaining the same rheological
behavior as HT [16].
Halloysite is a very special clay mineral due to its particular idiosyncrasies. Halloysite
is an isomorph of kaolinite, a layered clay mineral and member of the kaolin group, which
can naturally adopt different morphologies. In fact, in the classification of Guggenheim
and Martin, halloysite can be found in different groups depending on its final morphology:
planar, rolled or spheroids [11]. In particular, halloysite nanotubes (HNTs) result from the
curvature of newly forming halloysite silicate layers in the presence of water, thus forming
the characteristic tubular morphology of this clay Figure 2B.
Fibrous clay has a continuous tetrahedral sheet, unlike the octahedral ones, which
are discontinuous (Figure 2C). That is, SEP and PAL have continuous layers of tetrahe-
dra, though these tetrahedra suffer inversions every six or four units (for SEP and PAL,
respectively). As a result, tetrahedral apices point in opposite directions, forcing for a
spatial modification of the octahedral sheet, which is discontinuous. These discontinuities
create zeolitic channels within the structure. Coordination and charge balance are compen-
sated along the channels by protons, water (zeolitic water and crystallization water) and
exchangeable cations. The final crystal habit of SEP and PAL is fibrous or acicular, with
zeolitic channels parallel to the fiber length.
In terms of rheology, layered clay minerals in aqueous environments possess
“thixotropic” and “shear-thinning” behavior, which are the result of the combination
of both swelling capacity and their pH buffering activity. These properties can also be ob-
tained with fibrous clays, although in this particular case, the rheology will highly depend
on the concentration and mixing technique [17,18].
Due to their chemical composition and crystalline structure, clay minerals have the
ability to act as pH buffers. This property lies in the variations in the sign and density of
charges located in the silanols groups at the edges (Figure 3). In an acidic medium, the
excess amount of protons creates positive charges at the clay edge crystals, while negative
charges are caused by the dissociation of silanols and aluminol groups due to alkaline
environments. The knowledge of edge-charges of phyllosilicates is intimately related to the
rheological properties. The widely known “house-of-cards” or “card-house” aggregation
will occur when planar clay particles interact through the edge/faces of one another, thus
producing shear-thinning or thixotropic rheological profiles [19].
Figure 3. pH-dependent ion reactions at the edge of clay mineral layers.
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Moreover, clay minerals possess negatively charged particle surfaces due to isomor-
phic substitutions. This charge imbalance is compensated by free cations in the media
(Ca2+, Na+, K+, Mg2+, etc.), thus providing clay minerals with high adsorption capacity,
highlighted by their high specific surface area. These properties were widely exploited
for environmental remediation, catalysis and, more importantly for this review, drug
delivery [13].
1.2. Clay Minerals in 3D Printing
The combination of clay minerals and 3DP technology is a pretty recent field of study.
According to the database “Web of Science”, the major part of publications belong to
engineering, followed by materials sciences, chemistry and polymer science (Figure 4A).
The addition of “tissue engineering” keyword (Figure 4C) centers the attention to materials
science and cell biology. Apart from the novelty of 3DP, the combination of this technique
with clay minerals makes it an exponentially growing field, as can be seen by the evolution
of the number of publications per year (Figure 4B).
Figure 4. (A) Top 20 research areas with a higher amount of studies containing “clay” AND “3D printing”. (B) Number
of publications per year containing “clay” AND “3D printing” keywords. (C) Main research areas for “clay” AND “3D
printing” AND “tissue engineering”. Results obtained from database Web of Science. Current results in June 2021.
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This section gathers those studies dealing with 3DP and clays. The studies discussed
herein are somehow related to the biomedical field, or they could be of potential exploitation
in the biomedical field, regardless of whether the clay is a part of the ink or acts as an
“extra” or “support” ingredient for the 3DP process (Table 2). Layered clay minerals such
as MMT and LAP are the most widely used in this field. Natural MMT was combined
with high-density polyethylene (HDPE) in order to improve the polymer performance
and create 3D printing filaments [20]. HDPE is a polymer with extended use in medicine,
which was used as a bone substitute and orthopedic prostheses due to its remarkable
biocompatibility and mechanical properties. Nevertheless, HDPE possesses inadequate
rheological behavior, low modulus and poor bioactivity (bio-inert). Accordingly to the
study by Beesetty and co-workers, the addition of 5% w/w of clay provided “superior
mechanical performance”. Even if the final scope of this study was not related to medical
applications, the fact that both ingredients (MMT and HDPE) are biocompatible allows
these positive results to be potentially extrapolated to 3DBP and the production of different
medical devices.
Organo-modified clays are clays that have been subjected to a specific type of surface
functionalization. The organic functionalization of layered clay minerals is usually carried
out by grafting the clay mineral with cationic surfactants or other organic molecules that
are exchanged with the natural exchangeable cations present within the interlayer space of
the clay. Therefore, the organic molecule enters the interlayer space, occupying the place of
the exchangeable cations. Due to the larger size of these cationic surfactants, the interlayer
space (d-space) of the clay expands, allowing other molecules to enter. Cloisite® 30B (a
natural MMT functionalized with alkyl-quaternary ammonium salt) was combined with
polylactic acid (PLA), and the thermal and mechanical implications were studied [21,22].
PLA is a biocompatible and biodegradable polymer widely used in medicine [23,24].
Among its main properties, PLA possesses optical transparency and a high melting point
(>150 ◦C), the latter property being incompatible with cell-laden 3DBP processes. Nonethe-
less, PLA is very useful for the production of tailor-made implants and medical devices,
although the shape stability of the printed PLA objects still needs to be optimized. For
instance, the shrinkage that occurs after PLA crystallization can alter the final shape of the
3D printed object, giving rise to warped pieces (low shape fidelity). In this regard, layered
clay minerals such as MMT were proposed as PLA additives able to optimize printability
and reinforce mechanical properties. In fact, Cloisite® 30B enabled to increase the storage
modulus and the crystallinity of PLA [22]. Moreover, the melting temperature needed for
the printing process highly depends on the resultant architecture of the PLA/Cloisite®
30B nanocomposite, which can be modulated by the clay mineral. The elastic modulus
increased in all cases in which Cloisite® was involved [21]. Other types of functionalized
MMTs (Cloisite® 5 and Cloisite® 20) were also mixed with PLA, and their performance
compared with a natural sodium MMT (Na Cloisite®). The aim was to explore the in-
fluence of these minerals during 3DP fused filament fabrication [25]. On this occasion,
results clearly showed that the mechanical properties depend on the clay concentration
and type. For instance, Paspali and co-workers reported that tensile moduli increased,
while tensile strength and ductility reduced when MMT was used at 5% w/w. For the same
clay concentration, the organo-modified samples (PLA/Cloisite® 5 and PLA/Cloisite® 20)
reported better elasticity and strength than PLA/Na Cloisite®. This result was ascribed
to the interlayer space of each MMT sample. The functionalized samples showed an in-
creased interlayer space (d-space) due to the presence of the organic molecules, so these
clay particles were more prone to intercalate PLA during the 3D printing process, thus
explaining the better mechanical performance. Nonetheless, the Na Cloisite® possessed
the smallest d-spacing, hindering PLA intercalation [25].
Pharmaceutics 2021, 13, 1806 8 of 46








Increasing PLA crystallinity, melting








Improved mechanical properties of PLA
by organo-modified clay minerals due to
increased d-spacing of organo-modified
clay particles
Fused filament fabrication [25]
MMT—0.5, 1, 2, 5% w/w HDPE MMT provided superior mechanicalperformance Fused filament fabrication [20]
MMT (Cloisite®
SE300)—1, 3, 5% w/w
PETG
Mechanical reinforcement. Simplification
of the 3D construct post-processing or
post-treatment
Extrusion [26]
SEP—1, 2, 3, 5, 7% w/w PETG
Improvement of mechanical properties
due to directional alignment of SEP
particles within PETG filament
Fused deposition
modelling [27]
LAP—2.5% w/v Silk fibroin
Formation of a print-bed (in combination





Rheological modifier for 3DP and
mechanical reinforcement Extrusion [29]
LAP—12% w/v Pluronic
Improvement of printability and
mechanical properties of ink used as
sacrificial material template (mold) for the
production of microfluidic system
Extrusion [30]
In the case of synthetic clays, LAP demonstrated to favor the manageability of silk
fibroin (SK) for 3D printing. SK is a biocompatible, mechanically robust polymer with high
potential as a medical ingredient. The crosslinking of this polymer is subjected to the use
of other additives, jeopardizing the resolution and the final shape fidelity of the constructs.
In this regard, a recent one-step SF gelation was performed within a suspension of LAP
and PEG; the latter acted as a printing medium in where SF was left to crystallize [28].
In this process, PEG induced SF crystallization, while LAP would be working just as a
support and a rheology modifier. At the end of the process, LAP–PEG suspension was
easily washed with PBS solution, and the SF construct was easily extracted. In a similar
manner, LAP (12% w/v) was combined with pluronic (30% w/v) to be used as a template
to produce a 3D microfluidic system for an organ-on-a-chip device [30]. Briefly, the process
consisted of printing a template over which poly-dimethyl-siloxane (PDMS) organosilicon
was added and cured. Then, the pluronic/LAP ink would be eliminated to reveal a three-
dimensional, complex microfluidic system. To perform this, authors previously screened
different pluronic/LAP concentrations in order to select the most printable ink able to
support the pressure of PDMS afterward. In particular, the authors observed that high
amounts of LAP were needed to obtain enough printability and shape retention, with
filament collapse occurring below 8% w/v LAP. Nonetheless, a 12% w/v LAP concentration
revealed the good performance of the ink. Concentrations over this value compromised
the quality of the 3D template, probably due to the destabilization of pluronic micelles and
too numerous clay–clay interactions, which make the mixture too rigid and low printable.
The production of medical implants and other medical devices with adjustable and
tunable capabilities is of great interest. For instance, shape-changing constructs could be
of great use for vascular implants, endoscopic applications, tissue engineering, etc. In
this regard, N-isopropylacrylamide (NIPAM) and polyacrylamide (PAM) are synthetic
gels with differential thermal swelling responsiveness [29]. These two ingredients were
combined with LAP and proposed to produce 3D constructs with the ability to perform
time-dependent shape changes (elongation, expansion, bending, gripping). These shape
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changes were based on the differential spatial combination of both NIPAM and PAM
produced during 3DP (Figure 5). In both cases, LAP was used as a rheological modifier (to
allow 3DP) and mechanical reinforcement.
Figure 5. Shape-changing 3D constructs made of thermally responsive NIPAM/LAP swelling gel
(red) and PAAM/LAP (green). Figure reproduced with permission from [29], American Chemical
Society, 2019.
Finally, fibrous clay minerals (SEP and PAL) also demonstrated useful performances
as additives for 3D printing techniques. Their high aspect ratio can be of great use in
reinforcing 3DP polymers. For instance, SEP was incorporated into polyethylene glycol
terephthalate (PETG) for fused deposition modeling 3DP [27]. The results are quite note-
worthy and indicate that fibrous clay minerals could be of great use for the regeneration of
tissues requiring high mechanical strength, such as tendons, ligaments, muscles or bones.
Kim and co-workers added SEP to PETG in increasing amounts from 1 to 7% w/w. The
tensile strength and the elastic modulus grew with increasing SEP concentration. These
remarkable results were ascribed to the SEP particles directional alignment, parallel to the
deposition direction during the 3D printing process (Figure 6). SEP particles’ alignment
and their homogeneity within the formulation were addressed by means of electronic
microscopy (SEM, TEM) and small-angle X-ray scattering (often abbreviated as SAXS).
This way, SEP was confirmed as a great reinforcement of PETG polymer, something that
could be applicable to other biocompatible polymers.
Figure 6. Schematic representation of the directional alignment of SEP particles with PETG chains
during extrusion-based 3DP, according to the description and hypotheses reported in [27].
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As it can be seen, clay minerals are remarkable ingredients to modulate the final
mechanical properties of biocompatible materials with potential use in the fabrication of
medical devices and implants. They can also optimize the printing process by being either
added to the ink (where they can modify the rheology or the melting temperature of the
rest of the ink ingredients) or by acting as supplementary/supporting materials during the
printing process itself, such as for sacrificial material templates or printing beds.
2. Clay Minerals in 3D Bioprinting
A lower number of publications can be found when “clay” and “3D bioprinting”
keywords are combined. In fact, the scarce existing publications are centered in materials
science, engineering and chemistry (Figure 7A,C), indicating that the addition of clays is
more related to the mechanical and technical improvement for the 3DBP process. Despite
that, the potential role and usefulness of clay minerals in 3DBP are supported by the
increasing number of publications in which these inorganic ingredients were destined for
regenerative medicine and tissue engineering scopes (Figure 7B).
Figure 7. (A) Most important research areas of studies dealing with “clay” AND “3D Bioprinting”. (B) Number of
publications per year containing “clay”, “3D bioprinting”, “regenerative medicine” and “tissue engineering” keywords. (C)
Main research areas for “clay” AND “3D bioprinting” AND “tissue engineering”. Results obtained from database Web of
Science, June 2021.
The reasons for the usefulness of clay minerals in 3DBP are based on their properties
and traditional uses. Throughout the years, clay minerals have proven themselves as useful
rheology additives, showing shear-thinning behavior and viscoelastic profiles [16,31–37]
and are even commercialized as such (i.e., different types of Laponite® or Cloisite® products
series). In fact, this is a well-known feature: according to their structure, clay minerals such
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as SEP, PAL, MMT, HT and LAP are able to intercalate between polymer, polysaccharide
and protein chains to modify their rheological and mechanical properties and provide
crosslinking [3,27,38–40]. Moreover, clay minerals are naturally occurring materials whose
biocompatibility and bioactivity have already been reported and reviewed [41–48]. The
role of phyllosilicates as reinforcing materials for polymers and other ingredients was also
demonstrated [26,49–57]. Additionally, polymer/clay nanocomposites were demonstrated
to tailor cell detachment, cellular adhesion [58,59], cell-sheet formation [60] and to con-
trol the delivery of drugs and other bioactive molecules such as growth factors [61–63].
Moreover, natural clay minerals are naturally available resources with high availability and
affordability. Therefore, it is reasonable to think that clay minerals will also be adequate
and useful to improve BMI and BI formulations, awarding them with tunable rheological
and mechanical properties as well as to contribute with certain bioactive properties. One
of the objectives of this review is to offer an overlook of the most recent knowledge of
clay minerals as ingredients of BMI (Table 3) and BI (Table 4) formulations and their roles
during 3DBP and TE.
For a better understanding of the uses and/or potential uses of clay in 3DP, and
ultimately 3DBP, it is necessary to clarify the final scopes of BIs and BMIs together with
their most desirable characteristics enabling those scopes to be achieved. Precisely, the
following section is dedicated to defining and classifying the most desirable properties of
BIs and BMIs.
2.1. Desirable Bioink and Biomaterial Ink Properties
The success of 3DBP for TE lies in finding the right balance between a myriad of factors:
biocompatibility, printability, shape fidelity, functionality and mechanical properties of
the BI. Therefore, it is necessary not only to choose the BI or BMI ingredients carefully
but also the optimal combination and concentration of each of them. Apart from this, the
formulation performance also depends on the targeted tissue under regeneration, the cells
included in it (if applicable), the 3DBP technique chosen and the required post-processing
of the printed constructs. In other words, the key factor is the BI or BMI formulation.
2.1.1. Printability and Shape Fidelity
In the determination of the appropriate properties of a BI “shape retention” (or “shape
fidelity”) and “printability” are two concepts widely used. Shape retention or shape
fidelity is, precisely, the ability of a BI to retain its shape after the bioprinting process.
Those BIs whose 3D-printed constructs suffer from <10% change in length and width after
reaching equilibrium (compared to the dimensions of the CAD design) are considered
to have good shape retention. Printability can be defined as the ability of a BI or BMI
to be continuously extruded at a constant printing speed and pressure [4,64]. These two
properties highly depend on the rheology profile, which must be different depending on the
3DBP technique (Figure 8).
In general, for 3DBP, shear-thinning and viscoelasticity are crucial. A shear-thinning
profile is shown by a material whose internal structure is temporally disrupted when
subjected to stress forces such as shear and extensional flows (generated during processes
such as 3DBP) but immediately recovered once the stress is removed. Thixotropic materials
behave in a similar way, although the recovery of the material’s internal structure is time-
dependent (it does not occur immediately after the stress removal) [3,4,65–67]. On the
other hand, viscoelastic profiles are desirable to protect cells from shear stresses subjected
during the printing process [68]. It is also worth mentioning the fact that cells are prone
to alter the viscosity and rheology of the BI with respect to the corresponding BMI [69].
This modification of rheology produced by cells can be ascribed to the disruption of
some interaction points between the BI ingredients (e.g., breakage of polymer–polymer
interactions), something that would happen in a directly proportional manner to the
cellular density of the BI. Consequently, this parameter must also be optimized. Apart
from rheology, other qualitative tests can be used to measure printability and shape fidelity
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of BI and BMI. For instance, the filament collapse test (Figure 8A), filament fusion test
(Figure 8B), pore geometry and lateral pore collapse are some examples [68,70].
Figure 8. Up: schematic representation of “printability” and “shape fidelity” or “shape retention”
concepts. Middle: summary of some desirable rheological properties of BI and BMI based on three
3DBP techniques (extrusion-based, laser-based and droplet-based). High viscosities are acceptable
for extrusion-based techniques, although it is necessary to bear in mind that excessive viscosity
could hinder cellular viability. Droplet bioprinting or laser-based techniques require low viscos-
ity, though minimal values are needed to prevent cellular sedimentation. Down: qualitative and
semi-quantitative tests used to evaluate printability and shape retention: (A) filament collapse test;
(B) filament fusion test. Photographs for filament collapse and filament fusion tests were adapted
with permission from [70], Elsevier, 2021.
2.1.2. Biocompatibility and Functionality
Biocompatibility, non-immunogenicity and biodegradability are crucial for a BI or
BMI to produce 3D constructs applicable in TE (Figure 9). Biocompatibility is essential
to guarantee cellular viability (Figure 9C) [71–76]. The biocompatibility of 3D bioprinted
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constructs in vitro is usually determined by direct and indirect methods, following the ISO
10993-5 [77,78]. The absence of immunogenic response in vivo is important to ensure the
construct’s safety. Therefore, the in vitro immunogenicity tests are very valuable in the early
steps, which can be performed by determination of cytokine release/production [75,79,80].
Figure 9. Schematic summary of the main desirable biological features of BIs and BMIs. (A) and
(B) represent low immunogenicity of the BI or BMI, with low/absent cytokine release (A) and low
antibody recognition (B). (C) Biocompatibility and cellular viability. (D) Cellular proliferation and
differentiation. (E) The porosity of the BI and BMI allows for nutrients and gases diffusion throughout
the 3D construct. (F) Construct biodegradability. It is worth highlighting that the degradation process
must not result in the production of toxic metabolites.
The biodegradability of a 3D construct is desirable if total native tissue regeneration is
obtained. It means that the three-dimensional cell-laden structure ultimately disappears
from the treated area, being fully replaced by regenerated, totally functional native tissue.
Moreover, the biodegradation rate is very important: the construct must be able to maintain
its shape and function, at least until total recovery/regeneration. Consequently, the BI or
BMI ingredients must be wisely chosen and combined according to their biodegradation
rate [52,81,82]. Just as an example, hydrophobic and high crystalline polymers such as
poly(ε-caprolactone) undergo very slow biodegradation [83]. The biodegradation of some
ingredients, such as alginate, can also be induced by the addition of enzymes [84]. Likewise,
gelatin degradation can also be controlled by the functionalization degree, such as the
degree of methacrylation [85]. Regarding the monitoring techniques, the degradation rate of
the BI or BMI is mostly determined by gravimetric techniques [76,77,86,87], although other
methodologies such as rheology [88] or the detection of certain molecules or metabolites
were also used.
The functionality of a BI or BMI can be understood as their ability to enable tis-
sue regeneration, which implies the promotion of cellular proliferation, differentiation
(Figure 9c,d), and new tissue formation in the long term [71,72,75,89]. Additionally, good
porosity, both in the ink formulation and the resultant 3D construct, is also a guarantee
of BI or BMI functionality. Sufficiently porous BI or BMI formulation and/or printed
construct ensure the diffusion of gases (oxygen, carbon dioxide), nutrients and other ac-
tive substances such as growth factors (Figure 9e). Usually, the porosity can be analyzed
by microscopy techniques such as SEM [51,72,75] or by gravimetric/volumetric analy-
sis [76]. The intimate relationship between porosity and mechanical properties can also be
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found. In fact, it was reported that higher construct porosity leads to smaller mechanical
resistance [73], thus being crucial to find a compromise between them.
2.1.3. Mechanical Properties
The mechanical properties of BI and BMI must also be bore in mind, since they must
address the particular characteristic of the targeted tissue. Especial attention must be paid
if the BI or BMI is intended to substitute, repair or treat tissues involved in mechanical
functions such as bones, tendons or muscles (Figure 10). Therefore, the resultant printed
structures must support cells and newly formed tissue until total regeneration and resist
different stresses and deformations without jeopardizing the construct integrity or the
tissue functionality. Despite the numerous mechanical properties to which materials can be
subjected (stress–strain, tensile, shear, bending and twisting), stress–strain and tensile tests
are the most frequently addressed when it comes to TE 3D constructs.
Stress–strain tests are intended to subject the material to compressive forces. The
compression modulus quantifies the ability of a material to withstand compressive loads.
That is, it measures the ability of a material to change its length during compression. The
lower the compression modulus, the higher the flexibility (the material is less stiff). By
using a compressive test, it is possible to obtain different information about the elastic
behavior of the material: Young’s modulus, the plastic yield point and the compressive
strength [76,90–95].
Table 3. Biomaterial inks include clay minerals as part of their formula: clay type and concentration, final scope and main
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10–100 µg/mL GelMA 3D bone TE Osteoinductive ingredient; controlledrelease of VEGF [85]
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Rheological additives: HT induced
higher viscosities with lower
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LAP. HT performed higher printing
fidelity and faster construct
biodegradation
[81]
HNTs 2, 3, 4, 5% w/v ALG, MC,PVDF 3D cartilage TE Improved mechanical properties [91]












Figure 10. Crescent moduli of living tissues together with moduli of some TE materials. Tissues
and materials are organized by increasing crescent moduli. Reproduced with permission from [106],
Springer Nature, 2020.
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The tensile properties of a material are quantified by tensile tests. In particular, tensile
strength measures the ability of a material to withstand lengthwise stresses without fracture;
thus, the maximum amount of tensile forces that a material can withstand before failure. In
relation, the elongation at break is the length increase that the material will acquire during
a tensile strength test before breaking [21,27,91].
2.2. Use of Clay Minerals as Printability and Shape Fidelity Ingredients
Natural and synthetic clay minerals proved their useful and tunable rheological prop-
erties through the years. These inorganic ingredients were combined with a wide variety
of natural and synthetic polymers and macromolecules in an attempt to improve their
rheology or their printability properties. Even though it seems simple, the optimization of
printability by clays requires to consider several factors: the clay particle size, the possible
interactions (covalent and non-covalent) with the rest of the ingredients, the clay concen-
tration, the homogeneous dispersion of clay particles, the influence of the clay during the
post-processing steps and time-dependent rheological changes due to clay swelling, among
others. This section is devoted to the effects and influence of clay minerals as printability
ingredients of different BI and BMI in order to understand their roles.
Among clay minerals, there are not only differences in particle shape but also in
particle size, something that greatly affects the rheological behavior of clay suspensions.
The studies on the influence of clay particle size on BI and BMI printability are currently
scarce. Nonetheless, Schmieg and co-workers highlighted this factor when they compared
the rheology and printability of a natural, purified HT (commercialized as Bentone® MA)
with Laponite® RD (LAP) [81]. The final scope was to optimize the 3DBP of an enzyme-
laden poly(ethylene glycol) di-acrylate (PEGDA) BMI, meaning that no cells were added to
the formulation. HT induced higher viscosity than LAP but lower shear-thinning behavior.
This means that, when dealing with BI (cell-laden BMI), LAP would allow for better cellular
viability results. The higher shear-thinning behavior of LAP-based systems can be ascribed
to the smaller size of LAP with respect to HT. Nonetheless, the quality control of the printed





Figure 11. Shape fidelity of the printed PEGDA lattices using HT (left) and LAP (right) as rheological
additives. The bottom row shows the shape fidelity of the comparison with the desired structure,
graded with a color code. Blue shades depict a high accuracy or printing; Red indicates low confor-
mity. Areas with printing errors are marked with “x”. Reproduced with permission from [81], Wiley
Online Library, 2018.
As previously mentioned in the introduction, clay particles possess a negative net
charge in the interlayer space due to isomorphic substitutions. This, together with the
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silanol groups placed in the edges of the particle, makes them useful not only as rheology
modifiers but also as ionic crosslinking agents (Figure 12). For instance, carboxymethyl-
cellulose (CMC) and sodium alginate (ALG) was combined with MMT [70]. The resultant
printability of the BI was ascribed by authors to the establishment of intermolecular hy-
drogen bonds and electrostatic attractions between CMC, ALG and MMT. Figure 12b
represents the possible electrostatic interactions between clay nanoparticles and other
negatively charged polymers such as CMC and ALG.
Figure 12. Schematic representation of layered clay nanoplatelets structure and charges (central). (A) House-of-cards inter-
actions of clay nanoparticles in aqueous suspension after proper, homogeneous dispersion. (B) Clay particles interactions
with anionic macromolecules in an aqueous environment. The clay–polymer–clay interactions mediate the crosslink-
ing process. (C) Functionalization/organo-modification of layered clay mineral with an example of cationic surfactant.
(D) Schematic representation of neutral/cationic macromolecules “sandwiched” between layered clay nanoplatelets. The
increase in d-spacing after organo-modification makes clay particles more prone to intercalate molecules such as polymers
and macromolecules.
A PEGDA/ALG BMI is able to produce stretchable and tough 3D constructs intended
for cartilage tissue regeneration [97]. Nonetheless, the viscosity of the pre-gel solution
(that is, the BMI before crosslinking process) needed to be improved in order to obtain
enough shape fidelity. In that sense, the addition of 5% w/v of LAP provided enough
viscosity and a shear-thinning profile. The self-supporting ability provided by LAP to
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PEGDA was also explored with ALG and GEL [40]. In fact, PEGDA/LAP, ALG/LAP and
GEL/LAP 3D constructs were successfully printed in air, retaining their shape throughout
the whole printing process. In other words, it was possible to print the whole construct
and perform the corresponding chemical or physical crosslinking (which will award the
manageability) afterward: “printing-then-crosslinking”. The self-supporting capability of
6% w/v LAP was proved by the ability to print high, complex structures with inclination
angles of 45◦. Although Jin and co-authors reported that LAP nanoparticles participate in
the PEGDA, ALG and GEL crosslinking, the presence of any of these ingredients hindered
the thixotropy and yield stress values provided by LAP suspension [40]. This was probably
related to the concentration of the ingredients and the preparation procedure of the BMI.
Indeed, it was reported that excessive ALG concentrations could hinder the viscosity
provided by LAP due to excessive interactions between the anionic molecules of ALG and
the positive charges of LAP nanoparticles, preventing the formation of the house-of-cards
clay hydrogel network [107]. Another example of highly complex 3D constructs produced
thanks to the participation of LAP was reported for a BMI formulated with 0.5% LAP
and 2,2,6,6-tetramethylpiperidinyl-1-oxyl-oxidized bacterial cellulose (TEMPO BC) with
ALG [104]. Precisely, they were able to obtain nose and ear flexible constructs thanks to the
remarkable printability and mechanical properties of the resultant BMI.
Very recently, different BIs made of PEGDA, gelatin methacryloyl (GelMA) and LAP
(and their combinations) reported improved printability and high fidelity after the addition
of the nanoclay [69]. In fact, after LAP addition, the BIs were able to bridge a gap, something
that GelMA and PEGDA were not able to achieve. As it is well known, LAP provided
shear-thinning profiles and improved yield stresses. High yield stresses provide more
control over the deposition of the BI and, therefore, higher printability. Furthermore,
this particular study demonstrated that (i) the consistency of the final BI decreases after
the addition of cells (Figure 13A), which disrupt polymer–polymer and polymer–LAP
interaction points, and (ii) the printability and shape fidelity is highly dependent on
the infill density (Figure 13B). In fact, this BI was used to obtain a multicellular, free-
standing three-dimensional vascular model (Figure 13C) able to provide a “potential tool
to understand vascular disease pathophysiology” among others [69].
Different LAP concentrations (3, 4 and 5% w/v) were combined with GelMA to create
a BMI with acceptable printability [96,98,108]. As expected, the printability increased
with LAP concentration, as well as viscosity. In this case, the printing fidelity should be
sacrificed in cell-laden GelMA-LAP hydrogels since high viscosity would favor printability,
but it will also put at stake the cellular viability [96]. LAP also improved the printability
of oxidized alginate–gelatin (ALG-GEL) hydrogel [98]. More precisely, LAP increased the
viscosity of the BMI over time, probably due to the adsorption of anionic groups of gelatin
with the positively charged edges of LAP, leading to a crosslinking process. Authors also
speculated that NH3+ groups of gelatin could be interacting with the negatively charged
surfaces of exfoliated LAP particles, thus contributing to the hydrogel crosslinking. These
authors also reported the modification of the hydrogel pH due to LAP. The ability of
clay minerals to act as pH buffers lies in the variations in the sign and density of charges
located in the silanols groups at the edges (Figure 3). When working with BMI and BI, this
property of clay minerals should be taken into account since it could trigger either desirable
or undesirable chemical reactions (polymer crosslinking) or affect cellular viability. In
particular, Nerger and co-workers published the difficulties found during the 3D micro-
extrusion of type I collagen when combined with LAP [64]. Collagen is a fibrous component
of the ECM, its fibers serving as a scaffold and mechanical support of the tissue. In vivo,
collagen fibers are self-assembled, something that is not easy to accomplish in vitro. The
aim was to obtain anisotropic type I collagen 3D cell-laden constructs. Thus, the addition
of different shear-thinning ingredients was explored, among which LAP was selected. The
problem was that LAP and collagen were not compatible, resulting in a heterogeneous
BMI that frequently clogged the printing nozzle due to collagen aggregates. Authors
ascribed this incompatibility to the charged particles of LAP, which would be hindering the
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self-assembly process of collagen fibers [64]. Notwithstanding this hypothesis, the buffer
activity of LAP particles must also be considered. In aqueous media, the PZC (point of
zero charge or isoelectric point) of LAP particles is around pH 11 [109]. This means that
LAP, according to its buffer activity, would tend to raise the pH values or dissolve within
the acidic environment. If we take into consideration that collagen dissolves at acidic pH
and crosslinks in an alkaline environment, this could be another possible explanation for
the incompatibility reported by Nerger and co-workers: LAP could be causing a change in
pH that would trigger abrupt collagen crosslinking, preventing fibers from alignment and
jeopardizing printability.
Figure 13. (A) Rheological parameters of GelMA/PEGDA/LAP BI loaded with different cellular densities. (B) Dependence
of fidelity ratio with respect to the infill density (%) of the printed constructs. ** p < 0.05, *** p < 0.005, and **** p < 0.0001. (C)
Some interesting behaviors of the printed structures after 3DBP and curing. The formulated BI allows obtaining complex 3D
free-standing constructs that are able to absorb and retain fluids, something of great utility for vascular designs. Reproduced
with permission from [69], Wiley Online Library, 2021.
Increases in aqueous clay concentration usually lead to an increase in viscosity, which
is, in theory, desirable for extrusion-based 3DBP. Nevertheless, the nature and complexity
of BMI and BI make it difficult to predict how the clay concentration will affect the final
printability. Several studies revealed the necessity of systematic studies on this matter. For
instance, the rheology studies performed by Peak and co-workers revealed that “increasing
LAP concentrations decreased the recovery time due to incomplete destruction of internal
house-of-cards structure” [74]. Similarly, the higher the LAP concentration, the higher the
storage modulus of the hydrogel. Therefore, a rapid viscosity recovery was found for LAP–
PEG in comparison with pure PEG BI, which is undeniably desirable for bioprinting. The
high printability of this BI was demonstrated by a 23 layers-tall construct, printed without
any other support material. Very interesting was the conclusion that LAP < 4% w/v (for a
10% w/v of PEG) does not allow sufficient structure recovery, so the concentration should be
increased [74]. In a similar study, LAP and PEGDA were combined to serve as support for
a hyaluronic acid (HA) cell-laden BI [71]. The necessity of LAP concentrations higher than
4% w/v, when combined with PEG, was further confirmed by Zhai and co-workers, which
literally stated: “when less than 7% w/v nanoclay was added to the 20% PEGDA solution,
the printed scaffold could not maintain a fixed shape with fused microstructure” [71].
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The highest concentration limit was established to be 7% w/v, since higher LAP amounts
are reported to require excessive pressures at room temperature. PEGDA was recently
combined with de-cellularized cardiac extracellular cardiac matrix (dcECM) to obtain a BI
intended for cardiac 3DBP TE [92]. The use of dcECM is a guarantee for biocompatibility
and cellular viability of the resultant constructs, but the printing process, the myofibroblasts
differentiation and the construct performance after implantation are compromised due
to the poor mechanical performance of dcECM. Therefore, LAP was one of the selected
ingredients (together with PEGDA) that helped to improve the rheology, printability and
structural stability of the BI [92]. Thus, poly(ethylene glycol)-dithiothreitol (PEGDTT) is a
PEG able to be hydrolytically degraded and, therefore, more convenient for TE purposes.
Nonetheless, it shows too low viscosity on its own, limiting its use in 3DBP. The addition
of 4% w/v of LAP to PEGDTT made it possible to increase the viscosity and provide a
shear-thinning profile, thus improving printability and shape-retention [82].
N-isopropyl acrylamide (NIPAM), carbon nanotubes (CNT) and LAP were used to
formulate conductive, stretchable and adhesive hydrogels. The authors of this document
claimed that the printability of the NIPAM/LAP/CNT was appropriate [7]. Nonetheless,
the filament definition was arguable due to lumpiness (Figure 14). Moreover, some fila-
ment collapse was also visible. It is worth mentioning that the authors did not specify
the amount of LAP used, thus not being possible to discern how the clay mineral was
influencing the printability.
Figure 14. Three-dimensional printing behavior of different NIPAM/LAP/CNT BMIs (A–H) reported by Deng and
co-authors. Adapted with permission from [7], American Chemical Society, 2019.
The structure of clay minerals and, especially their specific surface area, makes them
able to absorb high amounts of water. This happens at different speeds depending on
clay type and concentration and influences the rheology of the resultant suspension. Nat-
urally, this factor will influence the printability of BMIs and BIs. Consequently, it is of
crucial importance to discern if the formulation rheology modifies with time in order to
perform the printing process in due course. This phenomenon was recently observed by
Sällström and co-workers, who added LAP to the photo cross-linkable N-(3-Sulfopropyl)-N-
methacroyloxyethyl-N,N-dimethylammonium betaine (SPE) [103]. The SPE/LAP suspen-
sions displayed low viscosities and Newtonian behavior just right after their preparation
(pre-gel), whereas higher viscosities and shear-thinning profiles were found 24 h later.
Therefore, the so-called pre-gel was considered not suitable for extrusion-based printing, re-
quiring 24 h of aging [103]. This result brings to the fore the importance of clay suspensions
“aging” or “maturation”. It is typical for clay minerals, especially for layered ones, to un-
dergo physicochemical changes with time after being dispersed in water [17,18,107,110,111].
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Among them, rheological changes are of special importance for 3DP and 3DBP. The major
part of short-time rheological modifications of clay suspensions can be ascribed to their
swelling capacity and high specific surface area. With time, the dispersion of clay nanopar-
ticles improves, exposing a higher surface area and, therefore, increasing the viscosity. As
an example, Jin and co-workers prepared LAP suspensions 24 h prior to being used as BMI
ingredient, thus allowing the clay hydrogel to set and swell properly [40]. This procedure
could be interesting to reduce the required amount of clay in BI or BMI by simply waiting
for it to age until maximum consistency.
The 3DBP process includes not only the printing itself but also the post-processing of
the construct to make it a structurally stable and manageable piece. Clay minerals have
also proven to be able to sway the post-processing of the printed construct. In this sense,
some polymers undergo gelation by physical mechanisms such as temperature changes.
In fact, during 3DBP, the temperature is a key factor since it will influence the rheology
and, more importantly, cellular viability. This factor is even more important when working
with thermoresponsive ingredients such as GEL and GelMA, among others. In these cases,
printability highly depends on the cartridge’s operating temperature, the print-bed and
the environment, as well as on the speed with which the thermoresponsive ingredient
changes from a solid-like to liquid-like state. The gelation temperature of thermoresponsive
ingredients can vary with the addition of clay minerals, as it was reported for kappa-
carrageenan (k-CA), agarose (AGA) and the block copolymer poly(2-methyl-2-oxazoline)-
b-poly(2-n-propyl-2-oxazine) (PMet-b-POxa) [102,112,113].
Regarding k-CA, its gelation temperature (around 40 ◦C) compromises the printability
of cell-laden inks. The addition of LAP to k-CA improved the printability of this polymer,
allowing the preparation of a suitable BI [113]. In particular, in the presence of 2–2.5% w/w
of LAP (LAP/k-CA composite), the k-CA gelation temperature was thoroughly reduced to
35 ◦C (Figure 15). Moreover, the yield stress and pressure required for the k-CA/LAP BI
extrusion was reduced by the clay mineral, while the recovery time of the final k-CA/LAP
BI was increased by the synthetic nanoclay. This was due to disruptions of the polymer–
polymer entanglements by interference with LAP nanoparticles. In conclusion, at least 4%
of LAP must be combined with 2.5% of k-CA in order to obtain a printable k-CA BI [113].
Figure 15. Interactions between LAP and k-CA polymer in a BI. Schematic representation of the crosslinking process of the
thermoresponsiveness and ionic gelation. Adapted with permission from [113], American Chemical Society, 2017.
Pharmaceutics 2021, 13, 1806 22 of 46
Another example of a thermoresponsive polymer is AGA, which highlights by its
thermal-reversible sol–gel transition, its biodegradability and biocompatibility. Nonethe-
less, it is a very complicated polymer to obtain good shape-fidelity constructs in 3DBP. This
difficulty is mainly related to the time required by the polymer to set once printed: AGA
setting requires rapid temperature changes. It was reported that the combination of AGA,
PAAM and LAP could be successfully used to obtain complex structures through extrusion
3DBP [99]. Further changes in gelation temperature of AGA by LAP can be found. Topuz
and co-workers combined AGA and LAP to prepare fibroblast-laden nanocomposites [112].
On this occasion, no 3D printing was performed, although authors reported that the gelling
temperature of AGA increased after LAP addition due to the chemical interactions between
the polymer and LAP surface. In particular, the gelation temperature of the AGA used
in this study shifted from 25 ◦C for pure AGA to approximately 37 ◦C when mixed with
4.5% w/v of LAP [112]. Therefore, it is crucial to optimize the effect of clay minerals over
thermoresponsive ingredients since it helps to select adequate conditions for 3DBP.
PMet-b-POxa behaves as a gel at temperatures higher than 20 ◦C, while sol behavior
can be found for temperatures below this value. The addition of LAP (1.4–1.7% w/w)
was reported to slightly alter the gelation temperature of the polymer [102], in agreement
with previous AGA observations reported by Topuz [112]. Printed strand fusion was
suppressed due to the presence of LAP, meaning that the shape fidelity was effectively
improved. Moreover, smoother and more uniform BMI strands were also obtained after
the addition of the synthetic clay mineral. The authors explained this result due to the
strengthening of the overall structure of the hybrid hydrogel as evidenced by an increase in
the elastic modulus (G′). Nonetheless, it is worth mentioning that high pressures were used
during the printing process (110–220 kPa), which could limit the use of this formulation as
BI due to potential cellular viability jeopardizing [102].
Functionalized or organo-modified natural clay minerals were used in BI and BMI
formulations. An organo-modified clay is a clay that has been subjected to a specific type of
surface functionalization. The organic functionalization of layered clay minerals is usually
carried out by grafting the clay mineral with cationic surfactants or other organic molecules
that substitute the natural exchangeable cations present within the interlayer space of the
clay. Under optimal conditions, the organic molecule enters the interlayer space of clay
nanoplatelets, occupying the place of the exchangeable cations. Due to the larger size
of these cationic surfactants, the interlayer space of the clay expands, allowing for other
molecules (e.g., polymers) to enter. An example of organo-modified or functionalized
clay minerals is Cloisite®® 30B, which were combined with bis-(2-hydroxyethyl) methyl
ammonium tallow molecules (Figure 12C).
Table 4. Bioinks, including clay minerals in their formula: clay type and concentration, final scope, and cellular viability.
Clay ClayConcentration
Rest of Bi




3% w/w ALG, MC 3D skeletal tissuesengineering
Mesenchymal stem
cells 70–75% [73]




>90% from day 7 [114]
0.5% and 1% w/v GG 3D bone TE Myoblasts 80% [115]
2.3% w/w dcECM,PEGDA 3D cardiac TE
Human cardiac
fibroblasts >97% in 7 days [92]




85% in 21 days [72]


















days 1, 3, and 7
[69]
7% w/v NAGA 3D bone TE Osteoblasts Not mentioned [89]
>4% w/v PEG 3D TE (target tissueundetermined) Pre-osteoblasts >90% in 21 days [74]
7% w/v PEGDA,HA 3D bone TE Osteoblast 95% after 1 day [71]
0–6% w/v k-CA 3D TE (target tissueundetermined) Pre-osteoblasts Not reported [113]
4% w/v PEG andPEGDTT
Control and direction
of cell migration HUVEC
85% just after 3D
bioprinting [82]











MMT 4% w/v CMC, ALG 3D soft-tissueengineering
Human pancreatic
cancer cells 84% after 7 days [70]
Cloisite®® 30B together with Cloisite®® 15A and sodium Closite® were studied as
ingredients of GelMA. GelMA is a photo-cross-linkable macromere with adequate biocom-
patibility to be used as an implant. In fact, GelMA properties were compared to gelatin,
thus being its potential substitute in 3DBP. Nevertheless, the low viscosity of GelMA
and the time required to be adequately cross-linked, difficult the printing processes. The
addition of the three types of commercial MMT (Cloisite®®) was reported to provide shear-
thinning behavior and increasing viscosity of GelMA, enabling the use of the resultant
BMI for TE purposes [105]. The highest viscosity was provided by a non-functionalized
sodium Cloisite®®, in comparison with the two functionalized counterparts (Cloisite®
30B and Cloisite® 15A). This manuscript is of special interest since it highlights another
important factor influencing the printability of BI and BMI with clay minerals in their
formulation. When it comes to clay minerals, a proper dispersion of the individual clay
nanoparticles could make a huge difference between a printed construct with acceptable
or non-acceptable 3DBP performance. In this regard, the printability of GelMA hydrogels
reported by Alexa and co-authors [105] was improved by the three of the MMT used with
respect to pure GelMA. Nonetheless, the functionalization of the clay particles (Cloisite®
30B and Cloisite® 15A) proved to hinder the homogeneous dispersion of the clay particles
within the GelMA matrix, thus clogging the printing nozzle occasionally and creating
discontinuous filaments.
2.3. Clay Minerals as Biocompatible and Functional Ingredients of Bioinks and Biomaterial Inks
2.3.1. Biocompatibility, Cellular Adhesion and Proliferation
Although the presence of an excessive amount of clay particles may be a problem for
cellular viability due to precipitation and endocytosis [41,116–119], various studies have
shown that certain amounts of clays in BI and BMI could positively impact the biological
performance of the constructs by many reasons.
Hong and co-workers added LAP to a PEGDA/ALG BI with the main objective to
improve printability [97]. Nevertheless, they discovered that the presence of the inorganic
ingredient gave higher viability of human embryonic kidney (HEK) cells (95% viability)
compared to the corresponding formulation without LAP (75% viability). A k-CA/LAP BI
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loaded with pre-osteoblasts proved good biocompatibility, as indicated by the even distri-
bution of cells within the 3D construct. Likewise, the cellular viability remained constant
for 7 days, something ascribed to the rheological properties provided by LAP [113]. Thus,
LAP has proved a good rheological ingredient to protect cells from suffering during the 3D
bioprinting process of a BI made of PEGDA/GelMA/LAP, with rather high cellular density
(0.5 million/mL–10 million/mL) [69]. This conclusion was obtained after determining that
cellular viability was >85% during the post-extrusion days (Table 4). Jin and co-authors
worked with one of the highest LAP concentrations (6% w/v) added to PEGDA, ALG and
GEL [40]. Despite that, the constructs reported good biocompatibility, cellular adhesion
and proliferation. In fact, the cellular adhesion was improved by LAP, which provided
“focal points” for the cells to adhere to.
Bio-inert polymers are those which do not initiate a response or interact when in-
troduced to biological tissue. This is of great use when it comes to avoiding immune
responses, but it is detrimental for cellular adhesion and proliferation since it hinders
the stimulation of tissue regeneration. In some studies, clay minerals were reported to
improve the biocompatibility of some ingredients such as AGA, which forms a bio-inert
hydrogel. With this specific scope, Topuz and co-workers formulated a BI made of LAP
and AGA [112]. NIH/3T3 fibroblasts were encapsulated in the AGA/LAP hydrogels,
the confocal microscopy analysis revealing cellular morphology maintenance, enhanced
cellular proliferation (higher metabolic activity) and spreading (Figure 16), something
that did not happen for pure AGA constructs. By incorporating LAP to 2-hydroxyethyl
methacrylate (HEMA), positive charges were introduced to a protein-free material for
3DP [101]. LAP was able to confer direct fibroblasts attachment along the 3D construct.
Figure 16. (a) Growth and cytoskeleton of fibroblasts cultured for a week in AGA gel; (b) growth
and cytoskeleton of fibroblasts cultured for a week in AGA/LAP BI containing 0.25% (w/v) of clay
mineral; (c) Metabolic activity of fibroblasts cultured within three different BI: pure AGA, AGA/LAP
with 0.25% and 0.5% (w/v) of LAP (mean ± SD, ** p < 0.01, n = 3). Reproduced with permission
from [112], Elsevier, 2018.
Human pancreatic cancer cells (BxPC3) printed within a CMC/ALG/MMT BI per-
formed an 84% cellular viability after 7 days [70]. This viability was reported to be higher
than some other BIs formulated with similar ingredients, indicating that the addition of
4% of sodium MMT has a remarkable potential to enhance biocompatibility and cellular
viability.
The in vitro viability and cell density of C2C12 pro-myoblasts increased for 21 days in
a very similar manner for the 3DBP construct made of gellan gum (GG) with or without
LAP [115]. Nevertheless, the implantation of the GG/LAP in the chorioallantoic membrane
of a 10-day-old developing chick produced a remarkable vasculature infiltration with
respect to the corresponding control.
A NIPAM/LAP/CNT BMI was assessed for direct toxicity against L929 fibroblasts.
Despite NIPAM being toxic on its own, Deng and co-authors reported otherwise [7]. In fact,
after 3 days, a higher number of cells was reported for the NIPAM/LAP/CNT sample with
respect to the control group. The authors did not discuss or hypothesize what could be the
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reason for that difference after 3 days of culture, though it could be related to the presence of
LAP, which was already reported to favor cellular adhesion and proliferation. For instance,
the presence of LAP in a cell-laden BI made of methylcellulose (MC) and ALG reported
homogeneous cellular distribution and higher viability (70–75%) than the corresponding
sample without clay (60–65% viability) in a time period of 7 days [73]. The number of
living cells was stable inside the 3DBP construct with LAP (3% w/w), whereas it reduced
when the nanoclay was not present. Another example of improved biocompatibility and
cellular viability results related to LAP can be found in a BMI made of 0.1% w/w LAP and
TEMPO BC/ALG. This formulation improved the in vitro L929 cells proliferation in the
early stages. On the other hand, the cells cultured on TEMPO BC/ALG with 0.5% w/w
of LAP “show better growth with larger spread area” than those on the corresponding
construct with 0.1% w/w of LAP [104].
The combination of LAP, AGA and PAM was demonstrated to be non-toxic to os-
teoblasts [99]. More precisely, an osteoblasts co-culture viability >90% was found after
3 days of contact with the 3D printed constructs. Poly(3,4-ethylenedioxythiophene) (PE-
DOT) 3D printed implants intended for the restoration of neurological functions were
combined with LAP and PAAM [100]. Intimate interactions between the implant and the
cells are crucial for optimal regeneration performance. Moreover, the system must mimic
the ECM as much as possible for neurons to make direct connections with the implant.
In these terms, the cellular adhesion over the raw LAP-PAAM-PEDOT printed structures
was not reported by Tondera and co-authors, leading us to think that the system by itself
was not able to favor cellular adhesion. Instead, a “biomatrix” made of PEG and dextran
sulfate was used to functionalize it and favor the adherence of human-induced pluripotent
stem cells and neurons [100]. On the contrary, an SPE/LAP BMI intended for lower limb
prosthetic socket implants showed to be not cytotoxic to the SH-SY5Y neuroblastoma cell
line, demonstrating its potentiality in neural applications. These in vitro cytotoxicity evalu-
ations were performed both by indirect and direct methods. Nevertheless, the authors also
reported that some improvement should be performed since cells grew to form clusters on
the hydrogel surface (lack of cellular spreading). Apart from that, improvement in some
mechanical properties such as the elastic modulus could allow for higher neural viability
and neurite extension of the cells [103].
Shin and co-authors [92] recently put the spotlight on the importance of the BI to
closely mimic the biological cues of the native extracellular environment, which is of
special interest for tissues such as the myocardium. Despite the fact that other natural
and synthetic hydrogels are considered biocompatible and allow for 3DP technology,
none of them are able to reproduce the properties and performance of the native ECM.
The use of decellularized extracellular matrix (dcECM) in TE has several advantages
since it preserves some of the growth factors, proteins and glycosaminoglycans specific
to each tissue. Nonetheless, dcECM itself is not adequate for 3DBP due to the lack of
mechanical and structural stability, which is further lost after decellularization. Therefore,
they proposed the use of partially digested dcECM in combination with LAP and PEGDA
in order to obtain a cardiac-biocompatible BI with tunable elasticity [92]. The elasticity
of this kind of tissue is crucial for the proper functioning of this tissue and myofibroblast
trans-differentiation. The addition of LAP to dcECM increased cellular survival after
7 days, showing the highest viability. As far as we are concerned, this is the first proposal
of a BI intended for cardiac therapy in which an inorganic material is included.
The inclusion of inorganic materials as “nanofillers” of biocompatible polymers in-
creases the surface irregularities and porosity of the resultant scaffolds [105,120]. Partic-
ularly in the case of BI and BMI, LAP was reported to be useful to increase the porosity
of GelMA and GG 3D printed constructs, and being potentially favorable for cellular
growth and enabling more effective diffusion of gases and nutrients through the con-
structs [96,115]. Other natural layered clay minerals such as MMT also reported similar
results with GelMA [105]. More precisely, the SEM analysis of GelMA printed struc-
tures combined with organo-modified and non-organo-modified MMT (Cloisite® Na vs.
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Cloisite® 15A and Cloisite® 30B) reported that the porosity size and shape depend on the
type of clay (Figure 17). Therefore, Cloisite® Na created larger pore sizes in comparison
with the pores of the constructs made of organo-modified clay minerals. On the other hand,
the highest pore roundness was ascribed to Cloisite® 15A and Cloisite® 30B [105].
Figure 17. SEM microphotographs of GelMA and different Cloisite®® formulations. The pore sizes
and shapes vary with the type of Cloisite®® used. Magnifications from top to botton: ×25, ×50, ×50,
×100 and ×1000. Reproduced with permission from [105], MDPI, 2021.
2.3.2. Biodegradation of 3D Printed Constructs
Owing to the intrinsic nature of the major part of BI and BMI ingredients, bioprinted
3D constructs tend to degrade with time, especially during in vitro or in vivo conditions.
The degradation rate of the 3D printed constructs is crucial to obtain a correct performance,
and it should be controlled in accordance with the final scope of the printed structure.
When it comes to TE, the degradation of the printed constructs will be determined by
the tissue regeneration speed (the healing process of the native tissue). The different
interactions between clay particles and the rest of the ingredients can interfere, under some
circumstances, interfere with the degradation rate of the printed constructs. In other words,
clay minerals can act as degradation rate controllers of 3D printed constructs.
The addition of 6% of LAP to 10% (w/v) PEGDA did not influence the degradation
rate of the cultured 3D construct with respect to pure PEGDA [40]. On the contrary, the
same concentration of LAP with 0.5% of ALG or 20% of GEL (w/v) proved useful to slow
down the degradation. GEL/LAP and ALG/LAP reported approximately a 20% reduction
in their degradation rates within 7 days, while pure GEL degraded in 1 day and pure ALG
took 3 days.
With PEGDA being such a stable polymer, it was proposed to create recoverable
enzyme-laden constructs for biocatalytic purposes [81]. For this particular scope, the
resultant printed structure should retain its form in the long term in order for it to be
reused and recycled. Therefore, a very slow or no degradation rate is preferred in these
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cases. Two-layered clay minerals were added to improve printability: HT and LAP. The
PEGDA/HT structures showed faster degradation (within hours) than PEGDA/LAP,
demonstrating LAP to be a better option in this particular case. Nonetheless, since HT gave
better shape fidelity and resolution than LAP (Figure 11), the use of HT could be considered
for other scopes such as the formulation of 3D printed modified drug delivery systems or
dissolvable tailor-made supports, implants or devices. It is also worth mentioning that
both ingredients (LAP and HT) exerted a minor influence on the intrinsic activity of the
laden enzyme, guaranteeing the activity of the protein [81].
A BMI made of GelMA and LAP was reported to possess good biocompatibility
against human umbilical cord vein endothelial cells (HUVEC) [96]. Good cellular adhesion
and proliferation were also found, notwithstanding the presence of LAP in the printed
scaffolds. On this particular occasion, the presence of LAP was also able to reduce the
degradation rate of the printed scaffolds in a directly proportional manner to the inorganic
ingredient concentration (Figure 18). In fact, an ear-printed shape remained stable after
1 week, suggesting that the scaffolds are useful for long-term TE treatments.
Figure 18. Degradation ratio of different GelMA/LAP bioinks for 7 days. Double asterisk (**)
indicates significant differences between groups with p-value < 0.01 (ANOVA). Reproduced with
permission from [96], IOP Publishing, 2019.
Lysozyme and bovine serum albumin (BSA) were chosen as analogs of bone mor-
phogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) [115]. The
final scope was to study the loading capacity and the release of both molecules (lysozyme
and BSA) from a BMI made of GG and LAP. Briefly, the 3DBP constructs were immersed
in solutions of each molecule to study the adsorption rate; subsequently, the release was
studied through collagenase digestion. The presence of LAP improved the adsorption rate
for lysozyme with respect to the pure GG construct, while it did not report differences for
BSA. Nonetheless, it helped to sustain the release of both molecules, even in the presence
of collagenase. This interesting result indicated that the sustained release of the factors was
more related to a delay in degradation of the constructs provided by LAP than to active
retention of the molecules under study [115].
The addition of increasing concentrations of LAP to a BMI made of TEMPO BC and
ALG [104] was demonstrated to significantly improve the structural stability of the 3D
printed constructs (Figure 19B). Although no biodegradation studies were performed on
this occasion (since authors were dealing with a BMI, not a BI), this result could infer the
hypothesis that the in vivo degradation rate of the implanted construct could potentially
be modulated by optimizing LAP concentration.
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Figure 19. Schematic representation of some of the functional roles of clay minerals in 3DP and
3DBP constructs. (A) Clay minerals as carriers of different active substances. (B) Effect of LAP
in biodegradation of ALG and TEMPO BC. Photos were reproduced with permission from [104],
Elsevier, 2020. (C) Osteoinductive effect of clays. (D) Clays were also proven to improve cellular
adhesion and alignment.
There are also studies relating the degradation rate of the 3DBP constructs with the
presence of clay but in an inversely proportional way. In other words, some studies have
proven that the addition of clay minerals accelerates or favors the degradation of the printed
constructs. For instance, the degradation rate of GEL/ALG/LAP printed constructs was
also related to the concentration of LAP particles within the printed structure [98]. This
degradation was monitored in buffer solution at 37 ◦C for 14 days. In comparison with
the constructs without LAP, those with 1% nanoclay had a more controlled gelatin release
behavior within 14 days of incubation, followed by a decrease in the release rate after
2 weeks. Nonetheless, all the printed structures with LAP in their composition reported a
faster degradation than the GEL/ALG counterpart (without LAP). Authors ascribed this
construct “liability” to the presence of LAP agglomerates due to improper clay dispersion
within the system. In a more recent study, the natural layered clay mineral MMT was
combined with GelMA [105]. Two organo-modified MMT (Cloisite® 30B and Cloisite® 15A)
and a non-functionalized MMT (Na Cloisite®) reported differential degradation rates of
the GelMA printed constructs. First of all, in comparison with pure GelMA, the addition of
MMT emphasized the degradation of the resultant hydrogels, something in agreement with
the study of Cai and co-workers [98]. In the study performed by Alexa and co-workers, they
stated that Cloisite® 30B and Cloisite® 15A were more difficult to disperse homogeneously
within the GelMA hydrogel; this is why they frequently clogged the printing nozzle.
Nevertheless, the functionalized clay (Cloisite® 30B, which was not properly dispersed
according to authors) reported the lowest degradation rate, followed by pure GelMA and
GelMA/Na Cloisite® (more properly dispersed) [105]. These results partially confirmed
the hypothesis of Cai and co-authors [98] but also raised new doubts about the mechanism
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of action through which layered clay minerals accelerate the degradation of gelatine-based
3D printed scaffolds. In any case, the homogeneous dispersion of clay particles within
the formulation is of great importance not only for proper printability (nozzle clogging,
etcetera) but also for long-term stability. This homogeneity should be accomplished by
means of a proper preparation procedure of the BI or BMI (pre-printing stage).
2.3.3. Carriers and Control Release of Functional Ingredients
Owing to the great adsorption capacity of clay minerals, they were widely explored as
potential drug delivery systems of conventional and modified dosage forms
(Figure 19A) [121]. Equally, in 3DBP, it is possible to find different studies dealing with the
influence of inorganic ingredients in the controlled release of bioactive substances. VEFG
and BSA are some of the most frequently explored. The combination of clay minerals with
traditional drugs usually leads to an irreversible release of a certain drug fraction that
remains “adsorbed” by the phyllosilicate [61,122]. This phenomenon was also reported for
VEGF and BSA molecules included within 3D constructs. It is particularly important to ex-
plore the release profile and to optimize the concentration of both the active ingredient and
the clay mineral, to ensure the release of a proper and effective dose, something that must
be performed on a case-by-case basis. Nevertheless, unlike oral clay-based dosage forms
(which have limited time to release the active ingredient), the 3D bioprinted constructs will
presumably remain in the targeted tissue for longer times (>8–10 h), and most of them are
designed to be completely degraded.
The release of BSA and VEGF proteins from an MC/ALG/LAP BI was strongly
influenced by the presence of the nanoclay (Figure 20) [73]. Both proteins suffered from
burst release in the absence of LAP, reaching a plateau within 1 or 2 days for BSA and
3 days in the case of VEGF. When the nanoclay was present, sustained BSA and VEGF
releases were found. The authors stated that significant amounts of growth factors were
retained by the clay since none of them was completely released in 21 days [73]. Even if the
total dose of VEGF and BSA was not released within 21 days, that does not imply that LAP
would completely retain the rest of their doses. Unlike BSA, which showed a progressive
reduction in the release rate of the protein (reaching a plateau in 14 days), the VEGF release
profile was almost linear during the whole experiment (21 days). These results indicate
that longer times are needed for the growth factors to be released. In fact, during the whole
period tested, the cumulative release of BSA and VEGF continued to increase. A reduction
in the final porosity of the construct in the presence of LAP together with the possible
electrostatic interactions between LAP, VEGF, BSA and ALG were identified by authors
as the responsible factors of the sustained slow release [73]. The influence of LAP in the
VEGF release was also addressed by Peak and co-workers. In this case, fibroblast growth
factor (FGF) was also explored, and both molecules were released from a 3D bioprinted
construct made of PEGDTT and LAP [82]. A 20% VEGF and FGF were released after 7 days,
reaching completion after 28 days. The rapid migration of HUVEC cells was ascribed,
indeed, to the sustained release of these actives from the printed structure. The release
profile obtained was ascribed to both the adsorptive capacity of LAP and to the degradation
rate of the system, which was also controlled by the clay nanoparticles (due to buffering
activity of LAP). The degradation rate of PEGDDT was found to be significantly shorter
in water than in PBS solution due to the pH modification caused by LAP. “Equilibrium
pH of nanosilicates (i.e., pH 9.4) causes a decrease in time needed for PEGDTT samples to
degrade” [82].
Apart from a controlled release of active substances, the presence of clay minerals such
as LAP was also shown to be useful to rapidly retain significant amounts of growth factors
within the bioprinted constructs. In this sense, Cidonio and co-workers demonstrated
that the presence of just 1% (w/v) of LAP was enough to obtain very effective adsorption
of lysozyme and BSA [115]. The effective role of LAP as a release controller of growth
factor was proved by Cidonio and co-workers in a more recent study, where the LAP-
based BI promoted vascular ingrowth and bone tissue regeneration in vitro, ex vivo and
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in vivo [114]. Therefore, BSA release can be effectively controlled and sustained with time
by the addition of 0.5% w/w LAP to TEMPO BC and ALG BMI [104]. In particular, this
study revealed that the addition of 1% w/w of LAP in the BI proved to be excessive, with
practically no BSA release. Similar results were reported with a wide variety of other
molecules such as drugs [121].
Figure 20. Release of BSA and VEGF proteins from MC/ALG/LAP constructs. The 0–3–9 stands for constructs made of
0% LAP, 3% ALG and 9% MC (wt), while 3–3–3 stands for 3% wt concentration of all the ingredients. Cumulative release
curves of BSA (a,b) and VEGF (c,d). Reproduced with permission from [73], Elsevier, 2017.
Direct in situ 3DBP processes are an advanced approach for TE and regenerative
medicine. These processes attempt to grant the practitioner the ability to print in situ tailor-
made 3D constructs perfectly adapted to the targeted area through a handheld device. In
these cases, the shape fidelity cannot be measured since there would be no “digital design”
to compare the construct with. Nevertheless, printability is still of great importance. Thanks
to the addition of LAP to GelMA polymer, Quint and co-workers were able to formulate a
supportive and adhesive BMI for in vivo handheld 3DBP with in situ photo-crosslinking
(Figure 21) intended to stimulate muscle regeneration [63]. On this occasion, the attention
was centered on the role of LAP as a VEGF carrier and release platform. This growth
factor was loaded into LAP through electrostatic interactions, and then the LAP-VEGF
nanocomposite was subsequently incorporated into GelMA hydrogel. A steady release
of VEGF over a 3 weeks period was observed, though there was a significant proportion
of non-released growth factors. Despite that, the scratch assay demonstrated effective
HUVEC cells stimulation [63].
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Figure 21. (A) In vivo handheld printing device aspect and composition of GelMA-LAP BMI, loaded with VEGF. The aim
of this BI and the handheld device was to treat skeletal muscle injuries through in situ 3D printing. (B) Photographs of
muscle-induced injury. Step 3 shows the handheld printing process, and Step 4 shows the finished restoration surgery.
(C) Optical microphotographs of scratch assay with HUVEC cells. “Fresh” results belonged to GelMA-LAP/VEGF BMI
crosslinked and subjected to scratch assay at time 0; “Presoaked” scratch assay was performed with crosslinked GelMA-
LAP/VEGF BMI pre-soaked in DPBS for 24 h before scratch assay; “Negative” control was composed of growth medium
without VEGF; “Positive” control test was performed by means of growth medium supplemented with 30 ng/mL of VEGF.
Figures adapted with permission from [63], IOP Publishing, 2021.
2.3.4. Clay Minerals as Functional Ingredients of Bioinks and Biomaterial Inks
Several activities were associated with clay minerals, thus acting as active substances
themselves. Their activities as gastrointestinal protectors, laxatives and antidiarrheals are
widely known [123]. Their favorable roles during wound healing were also extensively
reviewed, acting as hemostatics, wound healing promoters, antimicrobial agents and useful
wound dressing ingredients [15,42]. Apart from that, Gaharwar and co-workers reviewed
some immunomodulatory activity of clay minerals ascribed to their chemical composition.
More precisely, Li+, Mg2+ and Si(OH)4 were proven to enhance or trigger immunological
activity. Even if this statement would be contradictory to the desirable properties of a BI
or BMI, some studies reported a favorable tissue regeneration induced by these immune
responses [124,125].
Despite these already known features of phyllosilicates, in the specific field of 3DBP,
the usefulness of clay minerals’ therapeutic activities is still an unexplored topic. The main
results so far deal with their activities as osteoinductive agents. According to a recent
scientometric analysis, the most frequently reported bioprinted tissues within the last two
decades are cartilage and bone [1]. Bone tissue regeneration is based on the synthesis of
proper scaffolds able to facilitate cellular growth and to maintain the functional tissue
construct until the total reestablishment of the damaged area. However, it is still a great
challenge to achieve a proper level of cell deposition and distribution in 3D bone scaffolds
together with adequate mechanical properties.
Clay minerals reported outstanding results in bone and cartilage tissue regeneration
in vitro [126] since both natural [127] and synthetic clay minerals [116,128,129] have the
ability to stimulate bone regeneration thanks to their chemical composition (Figure 19C).
The exact mechanism of the action exerted by clay minerals in osteoinduction was related
to the release of elements from the clay structure [85,89], the triggering of certain im-
munomodulatory responses [130] and the cellular endocytosis of clay particles [116]. In the
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latter case, transcriptome monitoring of human mesenchymal stem cells (hMSC) subjected
to direct contact with LAP particles revealed that more than 4000 genes were differentially
expressed due to the presence of the clay mineral. Carrow and co-workers stated that
“nanosilicate attachment to the cell membrane and subsequent cellular internalization
activated stress-responsive pathways such as mitogen-activated protein kinase (MAPK),
which subsequently directed hMSC differentiation toward osteogenic and chondrogenic
lineages”.
N-acryloyl glycinamid (NAGA) polymer-based BI combined with LAP BI was eval-
uated in vitro and in vivo for biocompatibility and osteoinductive activity [89]. Firstly,
an increase in the concentration of NAGA was demonstrated to hinder cellular viability,
something that was ascribed to an excess of compactness of the BI. The presence of 7% w/v
LAP did not interfere with the viability of primary rat osteoblasts. Moreover, LAP was
considered responsible for the release of Si and Mg cations, which were able to diffuse
throughout the construct. Nonetheless, the increase in NAGA concentration (with constant
LAP concentration) reduced the release rate of these ions. The interference of NAGA with
Si and Mg release was ascribed to the reduced porosity, which could be a factor to bear in
mind for controlled release experiences. The activity of Si and Mg in osteogenic differentia-
tion was confirmed by the in vivo studies, where the NAGA/LAP implanted constructs
reported new bone formation. In comparison with the control, the NAGA/LAP 3D printed
construct produced thicker tissue formation. Moreover, no inflammation or other immune
responses were detected [89]. The osteoinductive activity of LAP was used later by the
same research group. On this occasion, a PEGDA/LAP BMI was combined in situ with
a cell-laden HA BI [71]. Both parts were combined during the 3DBP process by using
the so-called “two-channel method”, in which the HA BI provided the osteoblasts and
protected the cells from the UV light applied during the post-processing step, whereas the
PEG-LAP BMI acted as a supporting construct that provided stability, oxygen and nutrients
(including Si and Mg) toward the cells. In fact, tibia repair and ectopic osteoinduction
experiments confirmed that the environment around PEG-LAP favored cellular differentia-
tion [71]. Similarly, Byambaa and co-workers reported an osteoinductive activity of Na+,
Mg2+, Si(OH)4 and Li+ released by LAP [85]. Even if the release of these elements was
not monitored in this study, the mineralization was found to be higher as higher the LAP
concentration (10–100 µg/mL), which allowed to confirm the active participation of the
clay mineral [85]. Likewise, the osteogenic cellular differentiation effect was also observed
in GG/LAP constructs, as proved by an increased expression of alkaline phosphatase [115].
LAP dose-dependent bone mineralization was also supported by a BI formulated with
MC/ALG/LAP, together with VEGF and BMP-2. The resultant 3DBP constructs were
confirmed as viable and functional bone implants by means of in vitro, ex vivo and in vivo
studies [114]. Together with LAP, hydroxyapatite was also shown to be a useful inorganic
ingredient to carry and control the release of VEGF and BMP-2 growth factors from an
MC/ALG BI [131]. This controlled and sustained release reduced the necessity of using
supraphysiological doses of growth factors, thus reducing undesirable side effects.
The osteoinductive activity of natural clay minerals was also shown. Indeed, a natural
PAL was used as the main and major ingredient of 3D printed bone regeneration scaffolds
in combination with polyvinyl alcohol (PVA) as a binder (Figure 22A) [90]. Due to the
natural origin of the PAL sample (not commercial), it would have been convenient to
perform an assessment of the sample richness in order to discern the possible influence of
secondary mineral phases present (such as carbonates or hydroxyapatite). Nonetheless, no
information was provided on this matter, though the authors reported that a PAL purifi-
cation procedure was performed. In vitro (human Bone Marrow Stromal Cells, h-BMSC
cells) and in vivo (rat) biocompatibility and osteogenesis tests were performed. Besides
total biocompatibility, the PAL scaffolds induced direct bone formation by membrane ossi-
fication and re-vascularization in vivo. This effect was ascribed to the induction of BMP-2
and Runx2 genes, detected through real-time RT-PCR (Figure 22). Since the tested scaffold
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was purely made of PAL (the PVA was eliminated through carbonization at 500 ◦C before
in vivo implantation), the osteoinduction was strictly ascribed to the inorganic ingredient.
Figure 22. (A) Photograph of the PAL 3D printed scaffold. (B) mRNA expression of BMP2 and Runx2
genes quantified by real-time RT-PCR (p-value < 0.05). ATP stands for “PAL” and Blank stands for
“control group” indicating that those rats did not receive any treatment. (C) Compressive strength of
PAL scaffolds at different concentrations of clay minerals. Figures adapted from [90], Dove Medical
Pres Ltd, 2020.
2.4. Mechanical Reinforcement of Bioinks and Biomaterial Inks
Together with rheological modifications, another strong suit of clay minerals is their
role as mechanical reinforcement of a wide variety of ingredients. In particular, they pose
strong constraints on mechanical strength [132,133]. One of the main disadvantages of TE
and 3DBP constructs is their low mechanical resistance, mainly due to the nature of the
main ingredients (natural and/or synthetic hydrogels), the high amount of water and their
biodegradability. Despite the widely accepted usefulness of clay minerals as polymeric
reinforcement (especially of the organo-modified ones), the 3DBP is a novel and quite
recent technique that introduces new factors to bear in mind. Consequently, newly, specific
studies dealing with BI and BMI mechanical properties are needed. The existing literature
reveals that the mechanical performance of clay minerals depends on the interactions
between clay particles, clay particles and the rest of the BMI or BI ingredients, as well
as the possible clay–cells interactions. The complexity of the BI and BMI formulations
challenges the optimization of the mechanical resistance provided by clays. In this scenario,
the purity and richness of the inorganic ingredient are of great importance to maximize
the final performance and minimize the influence of external, unpredictable factors. This
may be an explanation for the number of studies dealing with synthetic clay LAP with
respect to natural ones, which are usually associated with a significantly higher number of
impurities.
Young’s modulus and energy dissipation of PEGDA, GEL and ALG were significantly
increased by the addition of 6% w/v of LAP [40]. This result was associated with the
high surface interactions between LAP layered nanoparticles and the polymers. Moreover,
the physical interactions between the nanoclay and the polymer chains award the final
formulation with viscoelastic properties, which could explain the energy dissipation.
The addition of LAP to an AGA/PAM nanocomposite provided better tensile and
compression strength [99]. Moreover, this hydrogel was demonstrated to be “recoverable”
in terms of shape and consistency. That is, the damage exerted over the constructs after
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the mechanical tests can be “healed” by heating the construct and “remodeling” its shape
(thanks to AGA) while maintaining its mechanical properties (due to LAP), Figure 23.
Figure 23. Shape modification of the 3D printed structure due to sol–gel transformation of AGA. The
softening and hardening cycles of complex printed structures (a,b); changes in storage modulus of
the hydrogels during heating/cooling cycles; (c) variations of storage modulus during heating and
cooling cycles. Reproduced with permission from [99], American Chemical Society, 2018.
LAP also proved to improve the mechanical properties of GelMA constructs. A printed
grid scaffold with 14 layers using GelMA/LAP (10% of GelMA and 4% or LAP) showed to
maintain either the grid pores of the digital design and also lateral pores formed during
the layer deposition, which is something not happening for those constructs with lower
or no LAP concentration [96]. This result was related to the higher mechanical support
that LAP gave to the hydrogel, thus allowing pore integrity. The strength and compression
modulus of this GelMA/LAP BMI also increased with increasing LAP concentration, with
the failure strain values not being affected by the clay presence [96]. Likewise, there
are studies reporting that the addition of clay does not have a significant effect on the
mechanical properties of GelMA BI or BMI. A BMI made of GelMA and LAP withstood
compression at 50% strain and reached up to 4.5 kPa as maximum compressive stress [63].
This value in comparison with native murine skeletal muscles (experiencing a maximum
of 40% of strain during contraction) demonstrates that GelMA/LAP BMI will allow the
printed constructs to deform during movement. Nonetheless, the presence of LAP did not
exert significant changes in the mechanical properties with respect to the corresponding
counterpart without LAP. Bearing in mind some factors already discussed in this review,
we hypothesize that this ineffective influence of LAP over mechanical properties could be
potentially related to inadequate clay concentration (not specified by Quint and co-workers)
or improper clay dispersion (vortex mixer was used for only 1 min) [63].
Another strategy with which clay minerals were reported to increase the mechanical
performance of natural hydrogels is the use of the two-channel method [71]. In this study,
LAP was combined with PEGDA and acted as a supportive BMI of a cell-laden HA BI.
This idea consists of using a more viscous BMI intercalated between the BI layers. In
particular, the compression strength values and compression modulus increased 4–3 times
after the addition of 7% w/v of LAP to PEGDA. It is also worth mentioning that the
Transmission Electron Microscopy (TEM) study demonstrated a homogeneous dispersion
of LAP nanoparticles within the BMI [71], proving that a homogeneous clay distribution
leads to better results. The mechanical performance of a BMI made of AGA, GEL and LAP
was monitored over time to reveal the influence of the in vitro conditions on the scaffold
maturation. The compressive modulus of the 3D printed constructs without LAP decreased
from day 0 to day 14. Contrary to expectations, the addition of LAP at 0.5 and 1% further
reduced the compressive modulus, even at time 0. This worsening of the BMI compressive
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modulus after the addition of LAP was ascribed to the presence of LAP agglomerates
within the hydrogel network due to improper or poor clay particles dispersion [98].
The tensile strength, Young’s modulus, elongation at break and compressive stress
of a NAGA polymer-based BI were improved by the “dual amide hydrogen bonding
interaction and physical crosslinking of the nanoclay–polymer chain” [89]. In fact, the
constructs with LAP were able to withstand strain, stretching and compression without
damage. Additionally, the swelling maintained stable and unchanged for longer times
with respect to the control, which is of great interest in reproducibility and maintenance of
the mechanical properties.
The thermoresponsive monomer NIPAM was combined with CNT and LAP to prepare
a BMI [7]. In this BMI, LAP was used as a physical crosslinker of the whole system. All the
BMIs prepared presented remarkable mechanical properties, which were clearly improved
by the presence of LAP in a directly proportional manner: as higher the LAP concentration,
the higher the compression modulus, the elongation at break and the tensile strength. Just
as an example, the tensile stress improved from 0.18 MPa for the BMI with approximately
7% w/w of LAP to 0.53 MPa, with 22% w/w of clay mineral (3 times higher). The same
increasing order was found for the compression modulus, whereas the elongation at break
was less affected by LAP, although increased values were also reported [7].
PEDOT was used as a base ingredient for the fabrication of 3D printed neuroprosthetic
implants to restore neurological functions [100]. Unfortunately, PEDOT does not possess
adequate mechanical and conductive properties for this scope. For instance, the printed
structures must resist deformation during body movements, handling and implantation.
Tondera and co-workers proposed the use of LAP and PAAM to provide elasticity, me-
chanical resistance and improved conductivity to the formulation. With respect to tensile
tests, the printed construct including LAP withstood 800% tensile strain before breaking.
In addition, it showed plastic deformation and recovery of the original length upon strain
relaxation. Regarding the conductivity, PEDOT typically requires to be doped with an
anionic polyelectrolyte such as polystyrene sulfonate to ameliorate its conductivity and
dispersion in water. The remarkable conductivity of the resultant LAP/PAAM/PEDOT
system was ascribed to the “introduction of mobile charge carriers (holes) in the PEDOT
backbone compensated by negative charges on the surface of LAP crystals” [100]. This
means that LAP, apart from playing a crucial role in the final mechanical and rheological
properties, was also providing the system with good electrochemical stability.
In the same manner, as the concentration of clay influences the final printability,
an optimal concentration of clay is necessary to obtain good mechanical properties. The
addition of small amounts of LAP (0.1% w/v) to a TEMPO BC/ALG hydrogel improved the
compression strength of the bioprinted structure from approximately 250 kPa to 330 kPa,
while higher LAP concentrations had little or no effect on the compressive strength [104].
The participation of LAP in the crosslinking process of TEMPO BC and ALG fibers could
explain this result since the “active” sites with which LAP could interact during the
crosslinking could be exhausted at 0.1% w/v, thus higher LAP concentration not having a
significant effect on the mechanical properties.
Despite the purity and richness provided by LAP, natural clay minerals are accessible,
abundant, sustainable and affordable raw materials. After proper purification, they can
also exert outstanding mechanical reinforcement for BI and BMI. For instance, the use-
fulness of natural MMT as a mechanical reinforcing agent was reported in combination
with GelMA [105]. In particular, three types of natural MMT, commercially available,
were combined with GelMA: sodium Cloisite® (natural MMT, Na Cloisite®), Cloisite® 30B
and Cloisite® 15A (functionalized MMT). The storage modulus indicated an increase in
the mechanical stability and stronger gel structure when MMT was added. Under stress
conditions, the addition of MMT helped to dissipate the compressive energy, notwithstand-
ing the type of clay. Nevertheless, the combination of GelMA with functionalized clays
(Cloisite® 30B and Cloisite® 15A) showed to be stronger than GelMA/Cloisite® Na [105],
in agreement with the results found by Paspali and co-workers [25].
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The natural, tubular clay mineral HNT was also tested as mechanical reinforcement
in 3DBP. In particular, HNTs were proposed as BMI ingredients in a study dealing with
cartilage regeneration [91]. Different concentrations of ALG, MC, polyvinylidene fluoride
(PVDF) and HNTs were combined to create a battery of BMIs that were subsequently
subjected to 3DBP. Both the tensile strength and compressive stress increased with HNTs
(Figure 24), so this natural clay was also identified as a good alternative to reinforce
polymers.
Figure 24. Compressive modulus, compressive stiffness, tensile strength and elongation at break of biomaterials combined
with different concentrations of HNTs. Reproduced with permission from [91], Elsevier, 2018.
High amounts of purified PAL (50–90% w/w) were combined with 10% of PVA and
extruded to produce ≈1 mm scaffolds intended for bone tissue regeneration [90]. No
cells were laden on this BMI since, after the 3DP, the constructs were dehydrated and
sintered at 500 ◦C to carbonize PVA. Mechanical tests showed that the compressive capacity
increased with the amount of PAL (Figure 22C). Therefore, the formulation with 90% of
PAL was selected and further characterized. In particular, the produced scaffold reported a
longitudinal compression strength of 4.3 MPa, very similar to the compressive strength of
native cancellous bone [90].
3. Future Prospects of Clay Minerals in 3D Bioprinting
At this point of the review, it is clear that one of the strong suits of clay minerals
is their rheological properties, which were exploited in a wide variety of areas such as
building industry, ceramics, drilling fluids, pharmaceutics, etc. [17,19,134–138]. Moreover,
both synthetic and natural clay minerals have proven to play a crucial role as mechanical
enhancers and functional ingredients. They even demonstrated extensive use as functional
ingredients. Therefore, it is plain to see the potential of these minerals in 3DBP and TE,
which has not been sufficiently exploited yet, probably due to its recent emergence. The
combination of an emerging technique as versatile and advantageous as 3DBP together
with the variety, abundance and versatility of clay minerals makes this a profitable field of
study with a wide variety of possibilities and opportunities. This section is dedicated to
the potential, unexplored or uncharted uses of clay minerals in 3DPB and TE.
Until now, all the studies mentioning improved cellular adhesion and 3DBP were
dealing with LAP (synthetic clay). Nevertheless, the promotion of cellular adhesion is
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also a well-known feature of natural clay minerals [43,59,139]. As an example, Naumenko
and co-workers proposed an implantable scaffold made of chitosan (CS), AGA, GEL and
HNTs for TE [120]. In this particular study, no cells were added to the scaffold, and no
3DP nor 3DBP technology was used. Nonetheless, results revealed that the scaffold was
biocompatible (both in vivo and in vitro), and, more importantly, cells were tightly attached
to its surface (Figure 19D). The in vivo studies in Wistar rats also showed full restoration
of blood supply in 6 weeks [120]. Moreover, the hydrophilicity and cellular adhesion of
3D printed structures of PLA were improved by HNT coating [140]. Therefore, the clay
mineral was not taking part in the BMI formulation (and therefore, not taking part in the
3DBP process). This approach was based on the idea that certain PLA printed patterns
were able to guide cellular orientation by means of “contact guidance” (Figure 25). Cellular
orientation is of use in the fabrication of cell-based biosensors, neural chips, cell arrays
or wound healing. Nonetheless, PLA does not show enough cellular adhesion for this
hypothesis to be proved. Thus, they turned to HNTs to improve cell affinity over PLA
structures and ultimately guide the orientation of stem cells.
Figure 25. (A) hMSC seeded over PLA/HNT 3D printed scaffolds and stained with fluorescein
isothiocyanate. Authors reported different stripe widths. (B) Cell counting and orientation degree;
the average cell orientation degree was summarized in (C). (D) Results of cell proliferation (CCK-
8) for 1, 3 and 8 days. OD stands for “optical density” quantified at 450 nm. Reproduced with
permission from [140], Elsevier, 2019.
The remarkable importance of clay minerals in drug delivery could also allow for the
carrying and controlled release of different drugs and bioactive molecules (such as growth
factors) in the targeted tissue. In this regard, LAP was already mentioned as a carrier of
VEGF and BSA in some BMI and BI [63,73,104,115]. Regarding other clay minerals, HNTs
were proposed as carriers of Ag in a 3D printed PLA construct intended as a biomedical
device to be used in wound healing [24]. This study was not included in any of the previous
sections because HNTs were not a strict part of the BMI. Precisely, the PLA constructs
(already printed) were subsequently soaked firstly into NaOH (to increase hydrophilicity)
and then in a CS-ZnHNT-Ag suspension. Therefore, HNT was used as a post-3D printing
functionalization ingredient to carry and release Zn and Ag, thus providing the printed
medical device with “anti-biofouling activity” against S. aureus and S. epidermidis.
The high specific surface area of clay minerals is also an attractive feature to be
exploited in 3DBP and TE, especially for treatments involving adsorption mechanisms. This
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feature was already exploited in a wide variety of areas, from environmental remediation
to healthcare and cosmetics. In fact, it is possible to find a recent study dealing with 3D
printed constructs made of ALG, MMT (Cloisite® 20A) and acrylic acid [141]. In this case,
the aim was not to produce BI or 3D structures to be applied as implants, medical devices,
or any sort, but to obtain adsorbent constructs for water remediation. The effective and
non-selective metal ion adsorption capacity was found, thus indicating that the formulation
was apt to be used for wastewater remediation [141]. As far as medical uses are concerned,
it was also reviewed that inorganic ingredients could be able to adsorb wound debris,
microorganisms and toxins from the wounded area [42]. In this regard, it is possible to
hypothesize that 3D printed scaffolds with clay minerals would be potential formulations
to control and/or prevent wound infections. Moreover, they are able to award wound
dressings with desirable features such as proper mechanical resistance and adequate
water-vapor transmission rate.
Another useful property of clay minerals is their ability to block UV radiation through
a physical mechanism; this is why they are used as sunscreen actives [142–144]. This
property can be useful to protect UV-sensitive molecules or actives within BMI or BI.
In particular, acrylonitrile butadiene styrene (ABS) is a widely used industrial polymer
sensitive to UV radiation, which accelerates its degradation. In a 3DP study, ABS constructs
were coated with an organo-modified MMT dispersed in dimethyl ketone after the printing
process. Briefly, the ABS printed constructs were immersed in different MMT suspensions
for different times, and the resultant surface properties were evaluated [145]. In particular,
the nanoclay coated constructs showed a significant increase in UV absorbance. Moreover,
the hardness of the construct was increased (by 9.7%), and the surface roughness was
reduced (by 94.9%). In this regard, we hypothesize that clay minerals could be of great
use for the production of 3D printed constructs carrying UV-sensitive actives, especially
if they are intended to treat skin affections and wounds (exposed to UV radiation). The
introduction of clay minerals within the BI, BMI or the production of coaxial 3DP with clay
minerals located in the most external layer would protect other UV sensitive molecules.
4. Conclusions
The adaptation and progress of the 3DP technology toward 3DBP (3D printing adapted
to biomedical purposes) has opened the door to a world of new opportunities and pos-
sibilities in the biomedical field. In fact, 3DBP enables the preparation of new dosage
forms, tailor-made devices and implants, tailor-made scaffolds for TE and many other
individualized therapy options. Until the appearance of this technology, TE approaches
were limited to two-dimensional cell sheets. Currently, 3DBP allows for the fabrication
of cell-laden artificial 3D tissues that can be even shaped as desired and individualized
for each patient and tissue. Nonetheless, the currently available materials used for 3DBP
usually fail to provide adequate rheological and mechanical properties. In an attempt to
meet these needs, synthetic organic macromolecules and inorganic materials are in the
spotlight. In particular, this document has reviewed the most recent advances and reported
uses of synthetic and natural inorganic clay minerals in 3DBP. The present review has
allowed us to conclude the following:
• Functionalized or organo-modified layered phyllosilicates (montmorillonite or ben-
tonite) are more prone to intercalate macromolecules within the interlayer space. This
ability was proven to enhance the mechanical properties of macromolecules such as
polymers;
• Fibrous (sepiolite and palygorskite) and tubular clay minerals (halloysite nanotubes)
were also proven to enhance the mechanical properties of certain macromolecules by
adjusting their orientation within the inkjet;
• Due to the chemical composition of clay minerals (aluminosilicates), they are promis-
ing materials for bone TE, with being able not only to provide mechanical resistance
but also to trigger osteoinduction;
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• Clay minerals were proven to induce cellular attachment, which is of great interest
to add anchor points for cells when working with 3D constructs made of synthetic
materials, for which cells usually do not show too much affinity;
• The high surface area of clay minerals makes them able to adsorb and carry a wide
range of molecules. In fact, this feature was exploited throughout the years for the
design and development of drug delivery systems. In the field of study at hand, clay
minerals were proven to control the diffusion of growth factors within 3D constructs,
something that could also be extended to the controlled release of other actives;
• Even if clay minerals are able to improve the viscosity of aqueous formulations, it is
not possible to predict the final rheological behavior of the formulation. Rheological
properties not only depend on the clay type and concentration but also on the prepara-
tion procedure and the different interactions between clay particles and the rest of the
ingredients in the environment. Bearing in mind that BMIs and BI are usually complex
mixtures, it is imperative to find the proper clay concentration for each formulation.
Finally, other uncharted or yet unexplored uses of clay minerals in 3DBP were also
hypothesized based on the already existing literature. In this sense, clay minerals can also
provide UV protection to UV-sensitive actives included in 3D constructs. This is of special
interest for the regeneration and treatment of light-exposed areas such as facial skin. The
high specific surface area and adsorption capacity of these minerals make them promising
ingredients for constructs intended to control and remove unwanted substances such as
debris, bacteria, fluids, toxins, etc., thus being interesting ingredients for the treatment and
regeneration of wounds.
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